| Price | 9.40p on 10-04-2026 at 15:40:00 |
|---|---|
| Change | 0.54p 6.07% |
| Buy | 9.50p |
| Sell | 9.30p |
| Last Trade: | Buy 10,000.00 at 9.44p |
| Day's Volume: | 4,449,548 |
| Last Close: | 9.44p |
| Open: | 8.90p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.10p - 9.44p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £100.86m |
| VWAP: | 9.251516p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 10,000 | 9.44p | Suspected BUY Trade |
16:35:06 - 10-Apr-26 |
| Sell* | 32,298 | 9.304p | Ordinary |
16:28:52 - 10-Apr-26 |
| Sell* | 15,000 | 9.304p | Ordinary |
16:28:14 - 10-Apr-26 |
| Sell* | 150,000 | 9.312p | Ordinary |
16:03:30 - 10-Apr-26 |
| Sell* | 58,064 | 9.30p | Ordinary |
16:01:35 - 10-Apr-26 |
| Buy* | 429 | 9.436p | Ordinary |
15:52:57 - 10-Apr-26 |
| Buy* | 2,642 | 9.436p | Ordinary |
15:50:45 - 10-Apr-26 |
| Sell* | 150,000 | 9.32p | Ordinary |
15:36:23 - 10-Apr-26 |
| Buy* | 10,570 | 9.46p | Ordinary |
15:11:18 - 10-Apr-26 |
| Sell* | 8,143 | 9.30p | Ordinary |
15:05:25 - 10-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
